For back-to-school, kids need more than new backpacks and books, but also an update on their immunization schedules. WTOP consulted Children’s National Medical Center Chief of Pediatric Infectious Disease Roberta DeBiasi, MD, to find out more about childhood immunizations.
Read the article
Want the latest Children’s National news and stories as they happen? Sign up to get our News & Events releases by email.
Children's National Health System researchers joining other teams have uncovered new evidence that T-cells, a type of blood cells, can effectively restore antiviral immunity after transplantation for some of the most high-risk viruses following transplant.
In the Atlantic, doctors weigh in on how the measles virus spreads and how the virus is making a comeback in the United States due to the unvaccinated.
The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group has found that treatment with the anti-viral medication valganciclovir for six months improves hearing and developmental outcomes over a two-year period for infants with congenital cytomegalovirus (CMV) infection. Roberta L. DeBiasi, MD, MS, Chief of the Division of Pediatric Infectious Diseases, Children's National Health System, is co-author of the study published in the New England Journal of Medicine.
Researchers found that an alternate, “escape” replication process triggered by apoptosis—the process of cell death or “cell suicide”—appears to be common in human herpesviruses (HHV).